William D. Clark - 02 Jun 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC.

Role
President and CEO, Director
Signature
/s/ DIANTHA DUVALL, ATTORNEY-IN-FACT FOR WILLIAM CLARK
Issuer symbol
N/A
Transactions as of
02 Jun 2022
Net transactions value
-$241
Form type
4
Filing time
03 Jun 2022, 16:11:27 UTC
Previous filing
02 Jun 2022
Next filing
25 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale $241 -4,023 -1.3% $0.0600* 304,377 02 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.